Condition: Cerebral Vasospasm · Aneurysmal Subarachnoid Hemorrhage (aSAH) · Sponsor: Vesalio
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
This description comes directly from the study's public registry record.
Sharon Shachar, Graduate · 2486976616 · sshachar@vesalio.com
Always discuss trial participation with your own doctor first.
| Providence St. Joseph Medical Center | Burbank, California, United States | Recruiting |
| John Muir Health | Walnut Creek, California, United States | Recruiting |
| Yale | New Haven, Connecticut, United States | Recruiting |
| Baptist Health South Florida | Miami, Florida, United States | Recruiting |
| Wellstar Health System | Marietta, Georgia, United States | Recruiting |
| Endeavor Health | Evanston, Illinois, United States | Recruiting |
| Univ Iowa | Iowa City, Iowa, United States | Recruiting |
| Univ Kentucky | Lexington, Kentucky, United States | Recruiting |
| MaineHealth | Portland, Maine, United States | Recruiting |
| Mayo Clinic- Rochester | Rochester, Minnesota, United States | Recruiting |
| Allegheny Health Network | Pittsburgh, Pennsylvania, United States | Recruiting |
| Geisinger | Wilkes-Barre, Pennsylvania, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06893588